Search Within

Samir Zaidi

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (6)
Groups
  1. GME, Medicine (13)
  2. GSK Faculty (13)
  3. Graduate Medical Education (13)
  4. Hematology-Oncology Fellows (13)
  5. Sloan Kettering Institute Postdocs (13)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)

More Groups

People
  1. Charles Sawyers (10)
  2. Wouter Karthaus (10)
  3. Joseph Chan (9)
  4. Dana Pe'er (7)
  5. Anuradha Gopalan (6)
  6. Jimmy Zhao (6)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (4)
  4. 2020 (1)
Publications
  1. Cancer Research (3)
  2. Journal of Clinical Oncology (2)
  3. Annals of Oncology (1)
  4. European Journal of Cancer (1)
  5. Journal of Nuclear Medicine (1)
  6. Nature Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Association for the Advancement of Science (2)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Inc. (1)
  5. National Academy of Sciences (1)
  6. Nature Research (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
    Journal Article

    Romero, R.; Chu, T.; González Robles, T. J.; Smith, P.; Xie, Y.; Kaur, H.; Yoder, S.; Zhao, H.; Mao, C.; Kang, W.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Effect of CDC7 inhibition and MYC degradation on neuroendocrine transformation in the lung and prostate cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Kawasaki, K.; Redin, E.; Rakhade, S.; Durani, V.; Sabet, A.; Karthaus, W.; Zaidi, S.; Zhan, Y. A.; Manoj, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
    Journal Article

    Quintanal-Villalonga, A.; Kawasaki, K.; Redin, E.; Uddin, F.; Rakhade, S.; Durani, V.; Sabet, A.; Shafer, M.; Karthaus, W. R.; Zaidi, S.; more...
    Signal Transduction and Targeted Therapy (2024)

    Fulltext@MSK | Save
  • Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen–targeted therapies
    Journal Article

    Zaidi, S.; Park, J.; Chan, J. M.; Roudier, M. P.; Zhao, J. L.; Gopalan, A.; Wadosky, K. M.; Patel, R. A.; Sayar, E.; Karthaus, W. R.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2024)

    Fulltext@MSK | Save
  • CEACAM5-targeted immuno-PET in androgen receptor-negative prostate cancer
    Journal Article

    Imberti, C.; De Gregorio, R.; Korsen, J. A.; Hoang, T. T.; Khitrov, S.; Kalidindi, T.; Nandakumar, S.; Park, J.; Zaidi, S.; Pillarsetty, N. V. K.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate
    Meeting Abstract

    Quintanal-Villalonga, Á.; Zaidi, S.; Karthaus, W. R.; Zhan, Y. A.; Shafer, M.; Qiu, J.; de Stanchina, E.; Haffner, M. C.; Sawyers, C. L.; Rudin, C. M.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
    Journal Article

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shafer, M.; Karthaus, W. R.; Zaidi, S.; Zhan, Y. A.; Manoj, P.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer
    Meeting Abstract

    Zaidi, S.; Chan, J. M.; Love, J.; Zhao, J.; Setty, M.; Lawrence, K.; Gopalan, A.; Goodrich, D.; Morris, M. J.; Chen, Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Multilineage plasticity in prostate cancer through expansion of stem-like luminal epithelial cells with elevated inflammatory signaling
    Meeting Abstract

    Zaidi, S.; Zhao, J.; Chan, J.; Martine, R.; Wadosky, K.; Gopalan, A.; Karthaus, W.; Watson, P.; True, L.; Nelson, P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversal of lineage plasticity in RB1/TP53-deleted prostate cancer through FGFR and Janus kinase inhibition
    Meeting Abstract

    Chan, J. M.; Karthaus, W. R.; Setty, M.; Love, J. R.; Zaidi, S.; Zhao, J.; Choo, Z.; Persad, S.; LaClair, J.; Lawrence, K. E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save